Achieving classical herd immunity against SARS-CoV-2, the virus that causes COVID-19, may not be attainable, according to a new perspective published in The Journal of Infectious Diseases. However, widespread use of currently available public health interventions to prevent and control COVID-19 will enable resumption of most activities of daily life with minimal disruption, the authors note. Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH; David M. Morens, M.D., senior scientific advisor to the NIAID director; and Gregory K. Folkers, chief of staff to the NIAID director, authored the perspective.
NIH experts discuss controlling COVID-19 in commentary on herd immunity
Achieving classical herd immunity against SARS-CoV-2, the virus that causes COVID-19, may not be attainable, according to a new perspective published in The Journal of Infectious Diseases. However, widespread use of currently available public health interventions to prevent and control COVID-19 will enable resumption of most activities of daily life with minimal disruption, the authors note. Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH; David M. Morens, M.D., senior scientific advisor to the NIAID director; and Gregory K. Folkers, chief of staff to the NIAID director, authored the perspective.